SINGULAR GENOMICS SYSTEMS IN's ticker is OMIC and the CUSIP is 82933R100. A total of 82 filers reported holding SINGULAR GENOMICS SYSTEMS IN in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $120,721 | -54.1% | 316,854 | 0.0% | 0.04% | -51.7% |
Q2 2023 | $262,989 | -31.4% | 316,854 | 0.0% | 0.09% | -43.7% |
Q1 2023 | $383,393 | -39.8% | 316,854 | 0.0% | 0.16% | -48.0% |
Q4 2022 | $636,877 | -80.7% | 316,854 | -75.9% | 0.30% | -80.0% |
Q3 2022 | $3,292,000 | -34.6% | 1,316,854 | 0.0% | 1.52% | -29.8% |
Q2 2022 | $5,030,000 | +12.7% | 1,316,854 | +86.1% | 2.17% | +51.8% |
Q1 2022 | $4,465,000 | – | 707,600 | – | 1.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Revelation Capital Management, LLC | 2,219,951 | $14,008,000 | 51.22% |
ARCH Venture Management, LLC | 3,798,926 | $23,971,000 | 3.43% |
Tikvah Management LLC | 707,600 | $4,465,000 | 1.43% |
Triatomic Management LP | 221,708 | $1,399,000 | 1.14% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,612,019 | $41,722,000 | 0.93% |
Perceptive Advisors | 3,655,207 | $23,064,000 | 0.46% |
Casdin Capital, LLC | 1,442,870 | $9,105,000 | 0.41% |
Orbimed Advisors | 2,300,792 | $14,518,000 | 0.24% |
Nicholas Investment Partners, LP | 519,885 | $3,280,000 | 0.23% |
Alphabet Inc. | 586,584 | $3,701,000 | 0.12% |